Clinical study about the intraocular surgery using the adjuvant.

Clinical study about the intraocular surgery using the adjuvant. - Clinical study about the intraocular surgery using the adjuvant.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029297

Enrollment

500

Registered

2017-10-01

Start date

2017-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The disease should be taken the intraocular surgery such as cataract or retina vitreous disease and others.

Interventions

Object:The patient should be taken the intraocular surgery such as cataract or retina vitreous disease and others. Interventions:The adjuvant is triamcinolone,brilliant blue G,indocyanine green an

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.The patient who was enough explained and understand this study. 2.The patient who agree this study by the free will and sign consent forms. 3.The patient who was diagnosed adjuvant is appropriate.

Exclusion criteria

Exclusion criteria: The patient who judged adjuvant is inappropriate by principal investigator or member of a research project.

Design outcomes

Primary

Measure	Time frame
visual acuity	—

Secondary

Measure	Time frame
1.surgery time 2.complication 3.intraocular pressure 4.electroretinogram study 5.specular microscope study 6.Laser flare cell meter study 7.optical coherence tomography study	—

Countries

Japan

Contacts

Public ContactTadashi Mizuguchi

Fujita Health University Ophthalmology

mizu@fujita-hu.ac.jp81-0562-95-5177

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026